Revumenib CAS No.2169919-21-3
Revumenib CAS No.2169919-21-3
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-2425 | 10mg | 340.00 | + Add to cart |
|
| R-R-2425 | 25mg | 680.00 | + Add to cart |
|
|
|
||||
Product description
Revumenib (SNDX-5613)/CAS No.2169919-21-3 is a potent and specific Menin-MLL inhibitor with a binding Ki of 0.149 nM and a cell based IC50 of 10-20 nM. Revumenib can be used for the research of MLL-rearranged (MLL-r) acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
| Appearance | N/A |
|---|---|
| Molecular Weight | 630.82 |
| Purity | >90% |
| CAS | 2169919-21-3 |
| Formula | C32H47FN6O4S |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Revumenib CAS No.2169919-21-3
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


